Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Jacobsen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Allergy and Immunology|March 27, 2004
Immunotherapy for the prevention of allergic diseasesLars Jacobsen
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|June 11, 2014
Current and future challenges for the allergen manufacturersLars Jacobsen, ,
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Preventive aspects of specific immunotherapyLars Jacobsen
Drugs of Today (Barcelona, Spain : 1998)|February 18, 2009
Prevention of asthma and allergiesLars Jacobsen
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|August 31, 2010
Primary and secondary endpoints in clinical trialsLars Jacobsen
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 21, 2010
Comparison of allergen immunotherapy practice patterns in the United States and EuropeLinda Cox, Lars Jacobsen
Current Opinion in Allergy and Clinical Immunology|November 9, 2007
How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?Lars Jacobsen, Erkka Valovirta
Clinical and Translational Allergy|April 17, 2012
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapyLars Jacobsen, Ulrich Wahn, M Beatrice Bilo
Emergency Medicine Journal : EMJ|January 22, 2022
Feasibility of prehospital identification of non-ST-elevation myocardial infarction by ECG, troponin and echocardiographyLars Jacobsen, Bjørnar Grenne, Roy Bjørkholt Olsen, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 27, 2018
The role of point of care ultrasound in prehospital critical care: a systematic reviewMorten Thingemann Bøtker, Lars Jacobsen, Søren Steemann Rudolph, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Allergy and Immunology|March 27, 2004
Immunotherapy for the prevention of allergic diseasesLars Jacobsen
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|June 11, 2014
Current and future challenges for the allergen manufacturersLars Jacobsen, ,
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Preventive aspects of specific immunotherapyLars Jacobsen
Drugs of Today (Barcelona, Spain : 1998)|February 18, 2009
Prevention of asthma and allergiesLars Jacobsen
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel) Langen/Hessen|August 31, 2010
Primary and secondary endpoints in clinical trialsLars Jacobsen
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 21, 2010
Comparison of allergen immunotherapy practice patterns in the United States and EuropeLinda Cox, Lars Jacobsen
Current Opinion in Allergy and Clinical Immunology|November 9, 2007
How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?Lars Jacobsen, Erkka Valovirta
Clinical and Translational Allergy|April 17, 2012
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapyLars Jacobsen, Ulrich Wahn, M Beatrice Bilo
Emergency Medicine Journal : EMJ|January 22, 2022
Feasibility of prehospital identification of non-ST-elevation myocardial infarction by ECG, troponin and echocardiographyLars Jacobsen, Bjørnar Grenne, Roy Bjørkholt Olsen, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 27, 2018
The role of point of care ultrasound in prehospital critical care: a systematic reviewMorten Thingemann Bøtker, Lars Jacobsen, Søren Steemann Rudolph, et al.
Pageof 3